98%
921
2 minutes
20
The administration of bioactive compounds presents challenges due to the numerous physiological barriers in the gastrointestinal tract. To deal with one of these challenges, chitosan (CHS)/carboxymethylcellulose (CMC) micropolyelectrolyte complexes (micro-PECs) were developed without the use of crosslinking agents to carry niacinamide, a model hydrophilic bioactive agent. A Box-Behnken design was used to study the effects of processing time (X = 60, 120 or 180 min), pH (X = 3, 4 or 5) and niacinamide concentration (X = 0.02, 0.04 and 0.06, g·L) on the encapsulation efficiency (Y) and loading capacity (Y) of niacinamide by CMC/CHS micro-PECs. The encapsulation efficiency (Y) varied from 0.86 % to 80.78 %, whereas the loading capacity (Y2) varied between 0.03 % and 3.89 %. The digestibility of CMC/CHS micro-PECs containing niacinamide was evaluated in vitro via a static gastrointestinal model. Empirical models (Zero Order, First Order, Higuchi and Korsemeyer-Peppas) were fitted to the niacinamide release kinetics data. The zero-order model exhibited the best fit across all points (gastric and enteric digestion), with low zero-order constants (K) ~ 0.002-0.003, indicating a regular and subdued release rate in all cases. These results highlight the applicability of CMC/CHS micro-PECs as an efficient, novel oral delivery system, surpassing conventional approaches by offering a sustained release and high encapsulation efficiency, without needing any additional chemical crosslinking agent for their obtention.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijbiomac.2024.137848 | DOI Listing |
Int J Pharm
September 2025
Department of Pharmaceutical Sciences, Via del Liceo 1, 06123 Perugia, Italy. Electronic address:
Indole-3-carboxaldehyde (I3A), a microbial tryptophan metabolite, exhibits significant immunomodulatory activity at the host-microbial interface. However, its rapid transformation into metabolites like indole-3-carboxylic acid (I3CA) raises questions about their therapeutic potential. This study aimed to evaluate the pharmacological contributions of I3CA through the development of a proper delivery strategy.
View Article and Find Full Text PDFACS Nano
September 2025
Department of Emergency and Critical Care Medicine, The Fourth Affiliated Hospital of Soochow University, Suzhou 215124, China.
Acute lung injury (ALI) is characterized by the excessive accumulation of reactive oxygen species (ROS), which triggers a severe inflammatory cascade and the destruction of the alveolar-capillary barrier, leading to respiratory failure and life-threatening outcomes. Considering the limitations and adverse effects associated with current therapeutic interventions, developing effective and safe strategies that target the complex pathophysiological mechanisms of ALI is crucial for improving patient outcomes. Herein, we developed an inhalable, multifunctional nanotherapeutic (MSCNVs@CAT) by encapsulating catalase (CAT) in mesenchymal-stem-cell-derived nanovesicles (MSCNVs).
View Article and Find Full Text PDFCrit Rev Food Sci Nutr
September 2025
State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, P. R. China.
Natural products have emerged as a vital source of active ingredients in medicine, food, and cosmetics due to their unique biological activities, safety profiles, and sustainability. However, most bioactive compounds in natural products are intensely bitter, limiting their use in pharmaceuticals and foods. The bitter taste attributes vary markedly among different compound classes, predominantly due to their structural characteristics.
View Article and Find Full Text PDFPharm Dev Technol
September 2025
School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, wenhua Road 103, Shenyang 110016, PR China.
Nimodipine (NMP), a poorly water-soluble small-molecule agent, demonstrates notable therapeutic limitations in addressing cerebral vasospasm secondary to subarachnoid hemorrhage (SAH). Owing to its inherent physicochemical properties characterized by low oral bioavailability, rapid elimination half-life, and extensive first-pass metabolism, conventional formulations necessitate frequent dosing regimens to sustain therapeutic plasma concentrations. These pharmacological challenges collectively result in suboptimal patient adherence, marked plasma concentration fluctuations, and recurrent vascular irritation.
View Article and Find Full Text PDFLangmuir
September 2025
Engineering Technology Research Center of Preparation and Application of Industrial Ceramics of Anhui Province, Engineering Research Center of High-frequency Soft Magnetic Materials and Ceramic Powder Materials of Anhui Province, School of Chemistry and Material Engineering, Chaohu University, Chaoh
In this study, a MoC-MoO@NCrGO-900 composite catalyst comprising two-dimensional nitrogen-doped reduced graphene oxide (NCrGO) and ultrasmall molybdenum carbide-molybdenum dioxide (MoC-MoO) heterojunctions was synthesized. The optimized catalyst exhibited an outstanding oxidative desulfurization (ODS) performance. Specifically, a model oil containing 4000 ppm sulfur was completely desulfurized within 30 min, with a desulfurization efficiency of 98.
View Article and Find Full Text PDF